Department of Rheumatology and Immunology, Shengjing Hospital of China Medical University, Shenyang, China.
Department of Rheumatology and Immunology, First Affiliated Hospital of China Medical University, Shenyang, China.
Panminerva Med. 2024 Sep;66(3):237-241. doi: 10.23736/S0031-0808.20.03990-7. Epub 2020 Jun 23.
The global hypomethylation of CD4 T cells in systemic lupus erythematosus (SLE) patients has been previously reported. However, potential influencing factors are unclear. This study aimed to uncover the potential influence of obese on hypomethylated CD4 T cells in SLE patients.
Obese SLE patients with Body Mass Index (BMI)>30 (N.=15) and normal weight SLE patients with 18<BMI<25 (N.=20) were included. SLEADI, antinuclear-ribonuclear-protein (nRNP) and dsDNA levels in them were detected. Methylation rate of CD4 T cells isolated from SLE patients was assessed, as well as its correlation to BMI and Systemic Lupus Erythematosus Disease Activity Index (SLEADI) in SLE patients. Subsequently, relative level and catalytic activity of DNA (cytosine-5)-methyltransferase 1 (DNMT1) were examined. New Zealand black/white (NZB/W) mice were fed high-fat diet for generating obesity model or normal diet, followed by detection of antinuclear-ribonuclear-protein (nRNP) immunoglobulin G (IgG), antidouble-stranded (ds) DNA IgG, methylation rate of CD4 T cells and DNMT1 level.
SLEADI, nRNP and dsDNA levels were higher in obese SLE patients than normal weight cases. SLEADI was positively correlated to BMI in included SLE patients. Compared with normal weight SLE patients, methylation rate of CD4 T cells was lower in obese patients. DNMT1 was downregulated in obese SLE patients, and its level was negatively correlated to BMI in SLE patients. Consistently, methylation rate of CD4 T cells and DNMT1 level remained lower in obese SLE mice than those normally fed mice with SLE.
Hypomethylated CD4 T cells extensively occur in SLE patients, which are much more pronounced in obese cases. DNMT1 level is found to be negatively correlated to the methylation rate of CD4 T cells in SLE patients.
先前已有研究报道系统性红斑狼疮(SLE)患者 CD4 T 细胞的全球低甲基化。然而,潜在的影响因素尚不清楚。本研究旨在揭示肥胖对 SLE 患者 CD4 T 细胞低甲基化的潜在影响。
纳入体质量指数(BMI)>30 的肥胖 SLE 患者(N=15)和 BMI 为 18<BMI<25 的正常体重 SLE 患者(N=20)。检测 SLE 疾病活动指数(SLEADI)、抗核核糖核蛋白(nRNP)和双链 DNA(dsDNA)水平。评估从 SLE 患者分离的 CD4 T 细胞的甲基化率,并分析其与 BMI 和 SLEADI 的相关性。然后,检测 DNA(胞嘧啶-5)-甲基转移酶 1(DNMT1)的相对水平和催化活性。对新西兰黑/白(NZB/W)小鼠进行高脂饮食喂养以建立肥胖模型或正常饮食,然后检测抗核核糖核蛋白(nRNP)免疫球蛋白 G(IgG)、抗双链 DNA IgG、CD4 T 细胞的甲基化率和 DNMT1 水平。
肥胖 SLE 患者的 SLEADI、nRNP 和 dsDNA 水平高于正常体重患者。SLE 患者的 SLEADI 与 BMI 呈正相关。与正常体重 SLE 患者相比,肥胖患者的 CD4 T 细胞甲基化率较低。肥胖 SLE 患者的 DNMT1 下调,且其水平与 SLE 患者的 BMI 呈负相关。同样,肥胖 SLE 小鼠的 CD4 T 细胞甲基化率和 DNMT1 水平均低于正常饮食的 SLE 小鼠。
SLE 患者广泛存在 CD4 T 细胞低甲基化,肥胖患者更为明显。DNMT1 水平与 SLE 患者 CD4 T 细胞的甲基化率呈负相关。